Recidiviz vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco nonprofit criminal justice AI platform (founded 2018); 16 state corrections partners, 156K people helped home, $1.3B+ savings, North Dakota 25% prison population reduction, Iowa partnership Sep 2024.
About
Recidiviz is a San Francisco, California-based nonprofit technology organization — funded by Arnold Ventures, Chan Zuckerberg Initiative, Mozilla Foundation, and Stand Together Trust — partnering with state departments of corrections to provide real-time data platforms, AI-powered case management tools, and decision-support systems that help identify incarcerated people eligible for early release, improve probation and parole supervision outcomes, and reduce recidivism at a systemic scale across the US prison population. Founded in 2018 by Executive Director Clementine Jacoby, Andrew Warren, and Joshua Essex — three former Google product managers who began the organization as a volunteer project while still at Google — Recidiviz started with seed funding of $150,000 from Y Combinator in 2019 and has grown to partner with 16 state departments of corrections as of 2024, including Idaho, Iowa, Maine, Missouri, North Dakota, Pennsylvania, Tennessee, and others. The organization's measured impact includes helping 156,000 people return home across all partner states, contributing to more than $1.3 billion in taxpayer savings, with projections showing over $3.8 billion in costs avoided and 245,000 life years given back to people in the justice system. In September 2024, Iowa Governor Kim Reynolds announced a partnership with Recidiviz, joining 15 other state corrections departments leveraging Recidiviz's platform.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.